A study showed krill oil demonstrated protective potential against a form of inflammatory bowel disease called ulcerative colitis that is characterized by inflammation and sores in the gastrointestinal tract. The study performed at the University of Bergen, Norway included 30 male rats divided into three groups: a control group, a group with induced colitis, and a group with induced colitis that received krill oil supplementation. The group that received krill oil supplementation showed significant preservation of colon length, a reduction of oxidative stress markers, and consistent beneficial changes as compared to the untreated colitis group.
"This study demonstrates the potential anti-oxidant and anti-inflammatory benefits of Superba krill oil for ulcerative colitis disease. Chronic inflammation is involved in other health concerns, including cardiovascular risk, joint discomfort, cancer, obesity, Alzheimer's disease, allergy, and diabetes," said Kjetil Berge, R&D Director of Aker BioMarine Antarctic. "The results from this study open up new possibilities for krill oil for digestive health, and may provide a basis for future studies in humans."
The health benefits of krill oil have been revealed through numerous studies and clinical trials. Previous studies have shown krill oil to have anti-inflammatory effects, but this is the first study to indicate the anti-inflammatory and protein antioxidant properties of krill oil in ulcerative colitis, a condition prevalent worldwide, but most commonly found in the United States (an estimated 1 to 2 million Americans have ulcerative colitis) and Northern European populations.
Superba(TM) Krill is sustainably harvested with eco-friendly methods in the Southern Atlantic Ocean near Antarctica.
Aker BioMarine Antarctic is the only krill ingredient marketer that is primary in its supply. Aker BioMarine Antarctic's proprietary Eco-Harvesting(TM) technology and on-board processing result in the unique composition of Superba(TM) Krill Oil and provide full traceability from sea to shelf. The Marine Stewardship Council (MSC) has granted MSC Certification to Aker BioMarine Antarctic's fisheries validating its sustainable harvesting and traceability, an exclusive distinction. As part of an established commitment to substantiating krill's health benefits, Aker BioMarine Antarctic continues to sponsor preclinical and clinical trials with krill oil containing omega-3 phospholipids, consistently demonstrating increased tissue accumulation of omega-3 fatty acids and improved blood lipid profiles compared to other omega-3 fatty acid sources.
The paper was published 30th November 2011 in Scandinavian Journal of Gastroenterology and is available at: http://informahealthcare.com/doi/abs/10.3109/00365521.2011.634025
About SuperbaTM Krill Oil
Superba(TM) Krill Oil is a pure, natural source of the health-promoting omega-3 fatty acids eicosapentaenoic acid (EPA) & docosahexaenoic acid (DHA) and the naturally occurring antioxidant astaxanthin. The uniqueness of Superba(TM) Krill Oil is that the major part of the omega-3 fatty acids are provided in phospholipid form. In vitro, preclinical and human clinical research has demonstrated the safety and efficacy of SuperbaTM Krill Oil.
About Aker BioMarine Antarctic
Aker BioMarine Antarctic is an integrated biotechnology company dedicated to the sustainable harvesting of krill and development of krill-derived biotech products. The company supplies biomarine ingredients through an optimized value chain from raw materials to customers. Aker BioMarine Antarctic's SuperbaTM Krill products are provided with 100% traceability from the Antarctic sea to the end user. Only Aker's krill fishery has been awarded Marine Stewardship Council (MSC) Certification.
For more information, please contact:
Matts Johansen, EVP Sales & Marketing, Aker BioMarine, +47 24 13 00 00
Kjetil Berge, R&D Director, Aker BioMarine, +47 24 13 00 00
Eric Anderson, Aker BioMarine Antarctic US,+1 206-855-6736 x 217
Roar Hernes, Aker BioMarine, +47 24 13 00 00
Chris McReynolds, Aker BioMarine, +1 206-660-6756